Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomized Midazolam & Fentanyl vs Dexmedetomidine for Procedural Sedation
NCT07166666Not yet recruiting
- Sponsor
- Oman Medical Specialty Board
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine, midazolam and fentanyl citrate nasal spray in Procedural sedation (PS) (2 arms), sponsored by Oman Medical Specialty Board. Primary endpoint: Depth of sedation at 1 year. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
dexmedetomidinemidazolamfentanyl citrate nasal spray
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT07166666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07166666.